Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio
Qianjiang Yongan Pharmaceutical Co Ltd cash flow-to-debt ratio. Qianjiang Yongan Pharmaceutical Co Ltd (002365) has a Cash Flow-to-Debt Ratio of 0.24x as of September 2025, meaning its operating cash flow of CN¥58.18 Million could theoretically repay 0% of its total liabilities (CN¥247.20 Million) in one year. Check cash flow quality index of Qianjiang Yongan Pharmaceutical Co Ltd to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Qianjiang Yongan Pharmaceutical Co Ltd (2006–2024)
Cash flow-to-debt ratio of Qianjiang Yongan Pharmaceutical Co Ltd from 2006 to 2024. Historical debt coverage capacity for Qianjiang Yongan Pharmaceutical Co Ltd across 19 annual periods. Check cash flow reinvestment rate of Qianjiang Yongan Pharmaceutical Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Qianjiang Yongan Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio by Year (2006–2024)
Qianjiang Yongan Pharmaceutical Co Ltd cash flow-to-debt ratio by year from 2006 to 2024. Year-by-year debt coverage analysis for Qianjiang Yongan Pharmaceutical Co Ltd. For the full cash flow conversion analysis, see Qianjiang Yongan Pharmaceutical Co Ltd cash conversion from operations.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.40x | CN¥105.71 Million | CN¥266.55 Million | ▼ -51.5% |
| 2023 | 0.82x | CN¥244.26 Million | CN¥298.85 Million | ▼ -32.2% |
| 2022 | 1.21x | CN¥387.28 Million | CN¥321.17 Million | ▲ +289.6% |
| 2021 | 0.31x | CN¥101.81 Million | CN¥328.95 Million | ▼ -47.6% |
| 2020 | 0.59x | CN¥206.66 Million | CN¥349.92 Million | ▼ -38.1% |
| 2019 | 0.95x | CN¥239.55 Million | CN¥251.14 Million | ▼ -1.9% |
| 2018 | 0.97x | CN¥314.02 Million | CN¥323.11 Million | ▲ +15.9% |
| 2017 | 0.84x | CN¥197.32 Million | CN¥235.23 Million | ▼ -4.5% |
| 2016 | 0.88x | CN¥84.53 Million | CN¥96.22 Million | ▲ +3.9% |
| 2015 | 0.85x | CN¥70.61 Million | CN¥83.50 Million | ▲ +247.4% |
| 2014 | 0.24x | CN¥19.26 Million | CN¥79.14 Million | ▼ -53.2% |
| 2013 | 0.52x | CN¥63.65 Million | CN¥122.50 Million | ▼ -14.4% |
| 2012 | 0.61x | CN¥70.75 Million | CN¥116.59 Million | ▼ -30.7% |
| 2011 | 0.88x | CN¥91.23 Million | CN¥104.13 Million | ▲ +51.4% |
| 2010 | 0.58x | CN¥44.06 Million | CN¥76.14 Million | ▲ +10.9% |
| 2009 | 0.52x | CN¥36.43 Million | CN¥69.83 Million | ▼ -60.5% |
| 2008 | 1.32x | CN¥158.47 Million | CN¥120.04 Million | ▲ +35.9% |
| 2007 | 0.97x | CN¥61.08 Million | CN¥62.89 Million | ▲ +44.4% |
| 2006 | 0.67x | CN¥31.11 Million | CN¥46.24 Million | — |